Rethinking treatment for nervous system disorders
Empowering patients to live on their own terms

Who We Are

At its core, Eliem is motivated by the promise of helping people live happier, more fulfilling lives. The Eliem team channels its experience, energy and passion for improving patients’ quality of life by developing life-changing novel therapies for neuronal excitability disorders based on clinically validated mechanisms of action.

Our Approach: Optimizing Treatments for Neuronal Excitability Disorders

Tens of millions of people suffer from central and peripheral nervous system disorders, where an imbalance between excitation and inhibition has disrupted the homeostasis in affected neuronal networks. These disorders include a range of common conditions such as chronic pain, depression, epilepsy and anxiety. Currently available treatments for these conditions often fail to provide adequate control or relief, and they are often poorly tolerated, leaving people unable to live life on their own terms.

Developing improved treatments for patients requires a pragmatic and diligent approach. Equal parts rigorous and agile, the experienced Eliem team strives to make treatments that are more effective, safer and better tolerated than currently available treatments. Leveraging clinically validated mechanisms of action, we are moving steadily and efficiently to develop novel therapeutics for neuronal excitability disorders that deliver enhanced outcomes for patients.

Our Pipeline

Our clinical and preclinical pipeline is focused on neuronal excitability conditions of the central and peripheral nervous system. We are developing ETX-155 for major depressive disorder and focal onset seizures. This compound is designed to dramatically improve on the limitations of existing therapies with the potential to be best-in-class for these conditions with high unmet clinical needs.

Our Experienced Team

Eliem is founded and led by a team of seasoned industry executives who collectively bring decades of clinical development and biopharmaceutical commercialization experience to the company. The team not only shares an unparalleled determination and passion to help patients, but they also have a history of working together to successfully build companies and bring novel and effective therapies to market. Eliem is also advised by a Board with considerable neurology research and development experience and a strong track record of building successful companies.

The team’s combined expertise in neurological research, clinical development, commercialization and company building are critical for delivering on the promise of bringing innovative therapies to market to provide relief and hope for the millions of patients affected by neurological conditions.
Leadership Team
Board of Directors
Valerie Morisset, Ph.D.
Executive Vice President, R&D and Chief Scientific Officer
Jo Palmer-Phillips, Ph.D.
Chief Development Officer
Andrew Levin, M.D., Ph.D.
(Chairman)
Judith Dunn, Ph.D.
Liam Ratcliffe, M.D., Ph.D.
Adam Rosenberg
Simon Tate

News

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash equivalents, including $120 million from a concurrent private placement of common stock from leading life

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

SEATTLE and CAMBRIDGE, United Kingdom, July 20, 2023 (GLOBE NEWSWIRE) — Eliem Therapeutics, Inc. (Nasdaq: ELYM) today announced that it has completed a review of its business, including the status of its programs, resources, and capabilities, and has made the determination to halt further
Load More

Careers

We are always looking to grow our team and believe it takes teamwork, trust and tenacity to deliver on the promise of helping patients live happier, more fulfilling lives. If this sounds like you, please indicate which position you are interested in and contact us at Careers US or Careers UK.

We’d love to connect.

Open Positions
SEC Reporting Senior Associate/Manager
SEC Reporting Senior Associate/Manager

Department: Finance

Hiring Manager: Controller

Effective Date: Immediate

Location: Remote, Greater Seattle Area, Washington

About Eliem:

Eliem is a dynamic, rapidly growing public company that is set to make significant strides in the life sciences industry. In April 2024, Eliem announced an agreement to acquire Tenet Medicines, Inc. and a concurrent $120 million private placement of common stock with a syndicate of new and existing institutional life science investors. The combined company plans to focus on advancing TNT119, a potentially best-in class anti-CD19 antibody, designed for a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy.

The acquisition and the private placement are expected to close in the middle of 2024, subject to Eliem stockholder approval and other customary closing conditions.

The company has teams located in both the US and UK. For further information visit our website: https://eliemtx.com.

About this role:

Are you ready for a change from public accounting and eager to apply your financial reporting and technical accounting expertise in an industry setting? Do you want to join a company that’s at the forefront of a dynamic industry, aiming to help patients lead happier, more fulfilling lives? If so, we invite you to join our growing accounting team as an SEC Reporting Senior Associate or Manager. In this crucial role, you will report to the Controller and collaborate with key internal and external stakeholders to ensure timely and accurate internal and external reporting in accordance with GAAP.

Responsibilities

  • Manage all aspects of our external SEC documents, including the 10K, 10Q, 8K and other ad hoc filings
  • Play a key role in implementation efforts and continuous monitoring of significant new accounting and SEC pronouncements including communicating and educating financial management on the updates
  • Lead efforts on technical accounting matters, including research and drafting of memos and policies
  • Complete disclosure checklists to ensure all requirements are met; stay updated on new pronouncements impacting disclosures; and maintain a repository of internal practices and peer company disclosures
  • Manage the preparation and support for all areas of our external reporting process, including EPS calculations, Balance Sheet, Income Statement, Statement of Cash Flows, Statement of Stockholders’ Equity, and Share-Based Compensation
  • Coordinate the review of filings with external auditors, legal counsel, accounting staff and executive management
  • Play a key role in the external audit process
  • Complete, document and communicate/present ad-hoc projects and analyses
  • Assist with the review of our annual tax provision and returns
  • Support Sarbanes-Oxley (SOX) compliance efforts, including the execution of financial reporting and equity processes controls.

Experience

  • Bachelor’s degree in Accounting/Finance and CPA required
  • Strong understanding of US GAAP and SEC reporting rules and regulations
  • Excellent organizational, verbal, and written communication skills
  • Proficiency in accounting research and problem-solving
  • 4+ years of experience in accounting; including Big 4 public accounting experience with exposure to public company reporting
  • Strong project management skills and the ability to manage a process, multi-task, work under pressure, and meet deadlines in a fast-paced work environment
  • Ability to build and maintain strong relationships with internal and external business partners
  • Ability to operate independently and as part of a larger functional team
  • Proficiency with Microsoft Office – Word, Excel, and PowerPoint

If you are passionate about leveraging your accounting skills in a thriving company and making a real impact in the life sciences industry, we encourage you to apply and become part of the Eliem team.

The physical demands described here are representative of those that must be met by an employee to successfully perform the primary functions of this job. This role is performed primarily from home with occasional site visits, the conditions of which may vary.

  • Work is normally performed in a home or professional indoor office work environment
  • Continuously remain in a sedentary position the majority of the day – employees are expected to create and maintain an ergonomic workstation
  • Operate a computer with time spent looking at monitor about 85% of the time
  • Communicate and exchange accurate information clearly with others
  • Continuously able to interpret visual content displayed on a digital screen
  • Very limited to no exposure to physical risk
  • Very limited to no physical effort required
  • Walk or stand occasionally
  • Use hands, wrists, and fingers to manipulate, control, or feel objects, tools, or equipment
  • Move about inside the office to access file cabinets, office machinery, etc.
  • Must be able to lift, move, push, pull, or otherwise manipulate objects of at least 10 pounds

The base pay range for this position at commencement of employment is expected to be $115,000-135,000. Base salary offered may vary depending on individual’s skills, experience, and competitive market value. Additional total rewards include discretionary annual bonus, comprehensive benefits to include Medical, Dental and Vision, short-term and long-term disability, company paid basic life insurance, 401k company match, generous paid time off and paid holiday, and stock options. Qualified candidates are encouraged to forward their resumes to CareersUS@eliemtx.com.

Eliem is an Equal Opportunity Employer and we do not discriminate against any employee or applicant for employment because of race, color, sex, age, place of origin, religion, family status, sexual orientation, gender identity, status as a veteran, and disability or any other federal, state, provincial or local protected ground.

SEC Reporting Senior Associate/Manager

Department: Finance

Hiring Manager: Controller

Effective Date: Immediate

Location: Remote, Greater Seattle Area, Washington

About Eliem:

Eliem is a dynamic, rapidly growing public company that is set to make significant strides in the life sciences industry. In April 2024, Eliem announced an agreement to acquire Tenet Medicines, Inc. and a concurrent $120 million private placement of common stock with a syndicate of new and existing institutional life science investors. The combined company plans to focus on advancing TNT119, a potentially best-in class anti-CD19 antibody, designed for a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy.

The acquisition and the private placement are expected to close in the middle of 2024, subject to Eliem stockholder approval and other customary closing conditions.

The company has teams located in both the US and UK. For further information visit our website: https://eliemtx.com.

About this role:

Are you ready for a change from public accounting and eager to apply your financial reporting and technical accounting expertise in an industry setting? Do you want to join a company that’s at the forefront of a dynamic industry, aiming to help patients lead happier, more fulfilling lives? If so, we invite you to join our growing accounting team as an SEC Reporting Senior Associate or Manager. In this crucial role, you will report to the Controller and collaborate with key internal and external stakeholders to ensure timely and accurate internal and external reporting in accordance with GAAP.

Responsibilities

  • Manage all aspects of our external SEC documents, including the 10K, 10Q, 8K and other ad hoc filings
  • Play a key role in implementation efforts and continuous monitoring of significant new accounting and SEC pronouncements including communicating and educating financial management on the updates
  • Lead efforts on technical accounting matters, including research and drafting of memos and policies
  • Complete disclosure checklists to ensure all requirements are met; stay updated on new pronouncements impacting disclosures; and maintain a repository of internal practices and peer company disclosures
  • Manage the preparation and support for all areas of our external reporting process, including EPS calculations, Balance Sheet, Income Statement, Statement of Cash Flows, Statement of Stockholders’ Equity, and Share-Based Compensation
  • Coordinate the review of filings with external auditors, legal counsel, accounting staff and executive management
  • Play a key role in the external audit process
  • Complete, document and communicate/present ad-hoc projects and analyses
  • Assist with the review of our annual tax provision and returns
  • Support Sarbanes-Oxley (SOX) compliance efforts, including the execution of financial reporting and equity processes controls.

Experience

  • Bachelor’s degree in Accounting/Finance and CPA required
  • Strong understanding of US GAAP and SEC reporting rules and regulations
  • Excellent organizational, verbal, and written communication skills
  • Proficiency in accounting research and problem-solving
  • 4+ years of experience in accounting; including Big 4 public accounting experience with exposure to public company reporting
  • Strong project management skills and the ability to manage a process, multi-task, work under pressure, and meet deadlines in a fast-paced work environment
  • Ability to build and maintain strong relationships with internal and external business partners
  • Ability to operate independently and as part of a larger functional team
  • Proficiency with Microsoft Office – Word, Excel, and PowerPoint

If you are passionate about leveraging your accounting skills in a thriving company and making a real impact in the life sciences industry, we encourage you to apply and become part of the Eliem team.

The physical demands described here are representative of those that must be met by an employee to successfully perform the primary functions of this job. This role is performed primarily from home with occasional site visits, the conditions of which may vary.

  • Work is normally performed in a home or professional indoor office work environment
  • Continuously remain in a sedentary position the majority of the day – employees are expected to create and maintain an ergonomic workstation
  • Operate a computer with time spent looking at monitor about 85% of the time
  • Communicate and exchange accurate information clearly with others
  • Continuously able to interpret visual content displayed on a digital screen
  • Very limited to no exposure to physical risk
  • Very limited to no physical effort required
  • Walk or stand occasionally
  • Use hands, wrists, and fingers to manipulate, control, or feel objects, tools, or equipment
  • Move about inside the office to access file cabinets, office machinery, etc.
  • Must be able to lift, move, push, pull, or otherwise manipulate objects of at least 10 pounds

The base pay range for this position at commencement of employment is expected to be $115,000-135,000. Base salary offered may vary depending on individual’s skills, experience, and competitive market value. Additional total rewards include discretionary annual bonus, comprehensive benefits to include Medical, Dental and Vision, short-term and long-term disability, company paid basic life insurance, 401k company match, generous paid time off and paid holiday, and stock options. Qualified candidates are encouraged to forward their resumes to CareersUS@eliemtx.com.

Eliem is an Equal Opportunity Employer and we do not discriminate against any employee or applicant for employment because of race, color, sex, age, place of origin, religion, family status, sexual orientation, gender identity, status as a veteran, and disability or any other federal, state, provincial or local protected ground.

Contact Us

MEDIA
INVESTOR RELATIONS
HUMAN RESOURCES
PARTNERING
Eliem Therapeutics, Inc.
PMB #117
2801 Centerville Road, 1st Floor
Wilmington, DE 19808-1609

Eliem Therapeutics (UK) Ltd: Reg. 11893311
3rd Floor, 1 Ashley Road
Altrincham, Cheshire WA14 2DT